Significados de ocular inflammation en inglés

Methods: Case report with a literature review of ocular inflammation in NBD.

Participants: Patients with uveitis at 4 US academic ocular inflammation subspecialty practices.

Signs of ocular inflammation postinjection had almost disappeared by 1 week.

The most common locations of ocular inflammation were posterior and panuveitis.

Purpose: A recent study revealed that angiotensin receptor signaling mediates ocular inflammation and neovascularization.

These data demonstrate that a delicate balance between sFasL and mFasL regulates ocular inflammation.

These results suggest the potential use of an AT1-R antagonist as a therapeutic agent to reduce ocular inflammation.

This approach has considerable potential for use in translational clinical therapy to prevent sight-threatening disease caused by ocular inflammation.

In conclusion, P-selectin may significantly contribute to the development of inflammation in the early stage of endotoxin-induced ocular inflammation.

Results: Of the 19 eyes, 14 showed moderate to severe ocular inflammation immediately after injection.

This mini-review starts with a brief overview of the literature in respect with the relation between ocular inflammation and depression.

To clarify the pathological roles of GHRH-R in acute ocular inflammation, we investigated the inflammatory cascades mediated by this receptor.

Participants: Patients with ocular inflammation followed at 5 United States tertiary centers that initially were neither diabetic nor taking hypoglycemic medications.

Tolfenamic acid (TA) was tested in two studies to investigate its value in controlling ocular inflammation in the dog.

Purpose: Recently, it was revealed that the inhibition of nonproteolytic activation of prorenin led to significant suppression of ocular inflammation in endotoxin-induced uveitis.

The expression of this molecule may be essential for succeeding processes of cellular infiltration and may determine the subsequent states of ocular inflammation.